Advertisement
Advanced Search

References

  1. [1]Zakon, S.J. Discovery of podophyllum resin. Arch Dermatol. 1952;65:620–622.
  2. [2]Kaplan, I.W. Condyloma accuminata. New Orleans Med Surg J. 1942;94:388–390.
    • [3]Mukherjee, A.K., Basu, S., Sarkar, N. et al, Advances in cancer therapy with plant-based natural products. Curr Med Chem. 2001;8:1467–1468.
    • [4]Huang, T.S., Lee, C.C., Chao, Y. et al, A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells. Pharmaceut Res. 1999;16:997–1002.
    • [5]Tian, X., Zhang, F.M., Li, W.G. Antitumor and antioxidant activity of spin labeled derivatives of podophyllotoxin (GP-1) and congeners. Life Sci. 2002;70:2433–2443.
    • [6]Mantle, D., Lennard, T.W., Pickering, A.T. Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adv Drug React Toxicol Rev. 2000;19:223–240.
    • [7]Mahe, E., Descamps, V., Bouscarat, F. et al, Management of external genital warts by dermatologists: a French survey. Ann Dermatologie Venereologie. 2002;129:997–1002.
    • [8]Wantke, F., Fleischl, G., Gotz, M. et al, Topical podophyllotoxin in psoriasis vulgaris. Dermatol. 1993;186:79.
    • [9]Lassus, A., Rosen, B. Response of solitary psoriatic plaques to experimental application of podophyllotoxin. Dermatologica. 1986;172:319–322.
    • [10]Larsen, A., Petersson, I., Svensson, B. Podophyllum derivatives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis. Br J Rheumatol. 1989;28:124–127.
    • [11]Gowdey, G., Lee, R.K., Carpenter, W.M. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol. 1995;79:64–67.
    • [12]Sirois, D.A. Oral manifestations of HIV disease. Mount Sinai J Med. 1998;65:322–332.
    • [13]Kao, W.F., Hung, D.Z., Tsai, W.J. et al, Podophyllotoxin intoxication: toxic effect of bajiaolian in herbal therapeutics. Hum Exp Toxicol. 1992;11:480–487.
    • [14]Chan, T.Y., Chan, J.C., Tomlinson, B. et al, Chinese herbal medicines revisited: a Hong Kong perspective. Lancet. 1993;342:1532–1534.
    • [15]But, P.P., Tomlinson, B., Cheung, K.O. et al, Adulterants of herbal products can cause poisoning. Br Med J. 1996;313:117.
    • [16]Chen, F.P., Chen, T.J., Kung, Y.Y. et al, Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res. 2007;7:26.
    • [17]Hong, C. Complementary and alternative medicine in Korea: current status and future prospects. J Altern Complem Med. 2001;7:s33–s40.
    • [18]Yamashita, H., Tsukayama, H., Sugishita, C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med. 2002;10:84–93.
    • [19]Napadow, V., Kaptchuk, T.J. Patient characteristics for outpatient acupuncture in Beijing, China. J Altern Complem Med. 2004;10:565–572.
    • [20]Eisenberg, D.M., Davis, R.B., Ettner, S.L. et al, Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569–1575.
    • [21]Wolsko, P., Ware, L., Kutner, J. et al, Alternative/complementary medicine: wider usage than generally appreciated. J Altern Complem Med. 2000;6:321–326.
    • [22]Tindle, H.A., Davis, R.B., Phillips, R.S. et al, Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health M. 2005;11:42–49.
    • [23]Chiang, S.H., Yi, H.Y. Chinese materia medical dictionary. The Commercial Press Ltd., Hong Kong; 1978 ([Chinese]).
      • [24]Chung, Y.C. Rernmirn weih Sheng Chu Printing Press. Research Institute of Chinese Medical Science, Peiping, China, ; 1979 ([Chinese]).
        • [25]Yang, C.M., Deng, J.F., Chen, C.F. et al, Experimental podophyllotoxin (bajiaolian) poisoning: III. Biochemical bases for toxic effects. Biomed Environ Sci. 1994;7:259–265.
        • [26]Sakurai, H., Miki, T., Imakura, Y. et al, Metal- and photo-induced cleavage of DNA by podophyllotoxin, etoposide, and their related compounds. Mol Pharmacol. 1991;40:965–973.
        • [27]Gordaliza, M., Castro, M.A., del Corral, J.M. et al, Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Design. 2000;6:1811–1839.
        • [28]Damayanthi, Y., Lown, J.W. Podophyllotoxins: current status and recent developments. Curr Med Chem. 1998;5:205–252.
        • [29]Chang, L.W., Yang, C.M., Chen, C.F. et al, Experimental podophyllotoxin (bajiaolian) poisoning: II. Effects on the liver, intestine, kidney, pancreas and testis. Biomed Environ Sci. 1992;5:293–302.
        • [30]Chu, C.C., Huang, C., Chu, N.S. Sensory neuropathy due to bajiaolian (podophyllotoxin) intoxication. Eur Neurol. 2000;44:121–123.
        • [31]Kao, W.F., Deng, J.F. Podophyllum. in: R.C. Dart (Ed.) The 5-minute toxicology consult. Lippicott Williams & Wilkins, Philadelphia (Pa); 2000:P592–P593.
          • [32]Chang, L.W., Yang, C.M., Chen, C.F. et al, Experimental podophyllotoxin (bajiaolian) poisoning: I. Effects on the nervous system. Biomed Environ Sci. 1992;5:283–292.

          Related Articles

          Searching for related articles..

          Advertisement